Impinj, Inc. PI
184.46 USD -1.61 (-0.87%)
At closeNov 3, 2026, 4:24 PM EST
184.46 0.00 0.00%
After hours · Nov 3, 4:24 PM ET
181.88 Day range 189.15
87.36 52-week range 215.25
- YTD
- +6.01%
- 1 year
- -1.71%
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 206.44 +11.9% upside
Now 184.46
- Target (low)
- 174.00
- Target (mean)
- 206.44
- Target (high)
- 225.00
Ratings (0m) 9 8 buy · 1 hold · 0 sell
- Strong buy2
- Buy6
- Hold1
- Sell0
- Strong sell0
Recommendation trend
- This month 9
- 1 month ago 9
- 2 months ago 9
- 3 months ago 9
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.04622 | -0.05 – 0.07 | -0.04 | +215.6% | 105.56M | +13.7% | 6 |
| Next quarter | 0.35971 | 0.21 – 0.43 | 0.14 | +156.9% | 94.94M | +27.9% | 7 |
| Current year | 2.28 | 2.22 – 2.39 | 2.11 | +8.0% | 398.15M | +10.3% | 9 |
| Next year | 2.85 | 2.51 – 3.24 | 2.28 | +25.1% | 474.81M | +19.3% | 9 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 2, 2026 | Barclays | Maintained | Overweight | Overweight |
| Oct 29, 2026 | Jefferies | Maintained | Buy | Buy |
| Oct 29, 2026 | UBS | Maintained | Neutral | Neutral |
| Oct 29, 2026 | Susquehanna | Maintained | Positive | Positive |
| Oct 29, 2026 | Needham | Maintained | Buy | Buy |
| Oct 12, 2026 | Barclays | Maintained | Overweight | Overweight |
| Aug 21, 2026 | BMO Capital | Initiated | — | Outperform |
| Jul 30, 2026 | Cantor Fitzgerald | Reiterated | Overweight | Overweight |
| Jul 30, 2026 | Needham | Maintained | Buy | Buy |
| Jul 30, 2026 | Jefferies | Maintained | Buy | Buy |
| May 1, 2026 | Barclays | Maintained | Overweight | Overweight |
| Apr 30, 2026 | UBS | Maintained | Neutral | Neutral |
| Apr 30, 2026 | Evercore ISI Group | Maintained | In-Line | In-Line |
| Apr 30, 2026 | Needham | Reiterated | Buy | Buy |
| Mar 16, 2026 | Roth Capital | Maintained | Buy | Buy |
| Mar 16, 2026 | Barclays | Maintained | Overweight | Overweight |
| Feb 6, 2026 | Barclays | Maintained | Overweight | Overweight |
| Feb 6, 2026 | Cantor Fitzgerald | Maintained | Overweight | Overweight |
| Feb 6, 2026 | Piper Sandler | Reiterated | Overweight | Overweight |
| Feb 6, 2026 | Needham | Maintained | Buy | Buy |
| Feb 6, 2026 | Evercore ISI Group | Downgrade | Outperform | In-Line |
| Jan 26, 2026 | UBS | Maintained | Neutral | Neutral |
| Jan 16, 2026 | Needham | Reiterated | Buy | Buy |
| Nov 7, 2025 | UBS | Initiated | — | Neutral |
| Nov 5, 2025 | Barclays | Maintained | Overweight | Overweight |
| Oct 30, 2025 | Evercore ISI Group | Maintained | Outperform | Outperform |
| Oct 30, 2025 | Cantor Fitzgerald | Maintained | Overweight | Overweight |
| Oct 30, 2025 | Needham | Maintained | Buy | Buy |
| Oct 23, 2025 | Piper Sandler | Maintained | Overweight | Overweight |
| Oct 22, 2025 | Susquehanna | Maintained | Positive | Positive |
